Thrivent Financial for Lutherans’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-49,798
Closed -$969K 2054
2018
Q1
$969K Buy
49,798
+3,597
+8% +$70K ﹤0.01% 1253
2017
Q4
$769K Buy
46,201
+911
+2% +$15.2K ﹤0.01% 1407
2017
Q3
$919K Buy
45,290
+660
+1% +$13.4K ﹤0.01% 1218
2017
Q2
$719K Sell
44,630
-251,870
-85% -$4.06M ﹤0.01% 1299
2017
Q1
$3.75M Buy
296,500
+256,310
+638% +$3.24M 0.02% 672
2016
Q4
$533K Sell
40,190
-75,329
-65% -$999K ﹤0.01% 1474
2016
Q3
$2.74M Sell
115,519
-53,350
-32% -$1.26M 0.01% 771
2016
Q2
$4.87M Buy
168,869
+3,190
+2% +$91.9K 0.02% 601
2016
Q1
$5.31M Sell
165,679
-75,430
-31% -$2.42M 0.03% 567
2015
Q4
$10.3M Sell
241,109
-140
-0.1% -$5.99K 0.05% 331
2015
Q3
$8.5M Buy
241,249
+36,200
+18% +$1.27M 0.04% 380
2015
Q2
$9.42M Buy
205,049
+7,200
+4% +$331K 0.05% 344
2015
Q1
$9.27M Sell
197,849
-26,400
-12% -$1.24M 0.05% 354
2014
Q4
$7.1M Sell
224,249
-4,350
-2% -$138K 0.04% 394
2014
Q3
$5.42M Sell
228,599
-55,950
-20% -$1.33M 0.03% 440
2014
Q2
$8.53M Buy
284,549
+208,249
+273% +$6.25M 0.05% 356
2014
Q1
$2.02M Buy
76,300
+52,700
+223% +$1.39M 0.01% 598
2013
Q4
$593K Buy
23,600
+300
+1% +$7.54K ﹤0.01% 918
2013
Q3
$477K Sell
23,300
-600
-3% -$12.3K ﹤0.01% 960
2013
Q2
$477 Buy
+23,900
New +$477 ﹤0.01% 950